Asclemed USA Inc. recalls Duloxetine DR Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
- Products
-
- Duloxetine DR Capsules
- Company
- Asclemed USA Inc.
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 50 bottles
- About this recall
- Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.